The IoMT for drug delivery market is projected to reach $10.09 billion by 2030 at a 9.0% CAGR, driven by connected devices, AI dosing, and remote patient care solutions.
Read More
The interleukin-2 (IL-2) mutein therapies market is set to reach $1.43 billion by 2030 at a 14.4% CAGR, driven by personalized immunotherapy and safer biologics.
Read More
The In Silico Drug Discovery market size is expected to reach $7.42 billion in 2030 at a CAGR of 12.1%, driven by pharma R&D investments.
Read More
The Implantable Neural Probes market size is expected to reach $3.56 billion in 2030 at a CAGR of 14.1%, driven by neurological disorder prevalence.
Read More
The Human Osteoblasts market size is expected to reach $53.09 billion in 2030 at a CAGR of 8.2%, driven by rising bone disease prevalence.
Read More
The Human Acellular Dermis market size is expected to reach $2.27 billion in 2030 at a CAGR of 6.6%, driven by plastic surgery expansion.
Read More
The Homozygous Familial Hypercholesterolemia market size is expected to reach $0.53 billion in 2030 at a CAGR of 7.6%, driven by early diagnosis initiatives.
Read More
The Homologous Recombination Pathway Panels market size is expected to reach $2.03 billion in 2030 at a CAGR of 12.7%, driven by targeted therapy adoption.
Read More
The High-Throughput Screening Services market size is expected to reach $39.06 billion in 2030 at a CAGR of 11.2%, driven by chronic disease prevalence.
Read More
The High-Fidelity Long-Read Sequencing market size is expected to reach $4.22 billion in 2030 at a CAGR of 22.5%, driven by rare disease prevalence.
Read More